{"id":"W3154344475","doi":"10.1164/rccm.202103-0612ed","title":"A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!","year":2021,"lang":"en","type":"letter","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rituximab; Scleroderma (fungus); Clinical endpoint; Randomized controlled trial; Pulmonary hypertension; Surrogate endpoint; Clinical trial; End point; Internal medicine; Cardiology; Physical therapy; Immunology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006192424,0.0006848289,0.002072245,0.0005638078,0.002055575,0.002760392,0.001688459,0.03167623,0.004538798],"category_scores_gemma":[0.02724833,0.0004407548,0.001125341,0.0006987915,0.001260259,0.002149889,0.0006522354,0.02095812,0.004946995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003306886,"about_ca_system_score_gemma":0.004158127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004437994,"about_ca_topic_score_gemma":0.00838843,"domain_scores_codex":[0.9956964,0.002056657,0.0005049296,0.0003614179,0.0009447073,0.0004358084],"domain_scores_gemma":[0.9813813,0.0127679,0.0009298067,0.0002958101,0.002298646,0.002326549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001757841,0.0002013742,0.002384969,0.0001489135,0.0001291697,0.00243367,0.00007686283,0.0001550681,0.0004605059,0.002126808,0.9608544,0.02927043],"study_design_scores_gemma":[0.009968154,0.001757422,0.008201884,0.001038124,0.0006312718,0.003744322,0.0004968542,0.003234935,0.00142939,0.01934902,0.9499475,0.0002010036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.001694181,0.001641437,0.0001808386,0.9749561,0.01784669,0.00003474851,0.0002548436,0.00003864033,0.00335264],"genre_scores_gemma":[0.01165816,0.001307833,0.0006078194,0.9355903,0.04550451,0.0001038557,0.0001776021,0.00003427405,0.005015782],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.03167623,"threshold_uncertainty_score":0.03274912,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08331659004783155,"score_gpt":0.383921509046636,"score_spread":0.3006049189988044,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}